Oct 29 (Reuters) - GE HealthCare Technologies ( GEHC )

raised its annual adjusted profit forecast and beat estimates

for third-quarter results on Wednesday, powered by strong demand

for its medical devices in the United States and the Europe,

Middle East, and Africa region.

Over the past couple of years, medical device makers have

benefited from more people, particularly older Americans,

seeking healthcare services and surgical procedures.

The company now expects 2025 adjusted profit of $4.51 to

$4.63 per share, 4 cents higher at the midpoint than its

previous expected range of $4.43 to $4.63.

It reiterated expectations of a $265 million, or

45-cents-per-share, impact this year from President Donald

Trump's tariffs.

But the estimate now includes the administration's 50%

levies on India and certain tariffs on copper, steel and

aluminum derivatives, GE HealthCare ( GEHC ) said on Wednesday.

Revenue in the imaging devices unit - the largest of its

four segments - rose 5% to $2.35 billion in the third quarter.

Its other three businesses are advanced visualization

solutions, patient care solutions and pharmaceutical

diagnostics.

Total quarterly sales came in at $5.14 billion, compared

with analysts' average estimate of $5.08 billion, according to

data compiled by LSEG.

Sales in China fell 3% to $547 million, still under pressure

from business disruptions tied to Beijing's anti-corruption

crackdown on the healthcare sector, as well as delays in

economic stimulus.

On an adjusted basis, GE HealthCare ( GEHC ) earned $1.07 per share

during the quarter ended September 30, higher than estimates of

$1.05 per share, but down 6 cents from last year due to a hit

from tariffs.